This announcement is a separate document:
武田薬品工業：当社取締役に対する株式報酬制度および国内の当社幹部に対する株式付与制度の 2024年における継続について
Takeda Pharmaceutical: Continuation of the stock compensation system for our directors and the share grant system for our domestic executives in 2024
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.